- Resources
Drug Which Prevent Osteoporosis And Breast Cancer
The osteoporosis med Evista may help prevent certain kinds of breast cancer, a new study suggests. The drug is already approved for women who are at high risk of breast cancer, but the new study suggests it may help other women as well. California researchers found that post-menopausal women who took the drug for several years were 55 percent less likely to develop invasive, ER-positive breast cancer than women who did not take the med.
Read moreMore information on "Drug Which Prevent Osteoporosis And Breast Cancer"
From Our Experts
Evista (Raloxifene), Breast Cancer and Osteoporosis
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Osteoporosis after Breast Cancer
Lila de Tantillo, an expert from our partner site OsteoporosisConnection.com, discusses osteoporosis as a side effect of breast cancer... Read more »
Breast Cancer and Osteoporosis: Beware the Connection
When you’re diagnosed with breast cancer, it becomes the Big Gorilla in the corner, healthwise. The sore throat, head cold, or heartburn... Read more »
Breast Cancer News: Drugs, Implants, and Prevention
A thoughtful column in the Washington Post this week makes a good point: that the public and the media may be too quick to jump on... Read more »
Osteoporosis Prevention: Not All Exercise Is Created Equal
I’m a breast cancer survivor, and thus am able to take advantage of a new medical initiative that’s sweeping across the country:... Read more »
From Our Sources
Osteoporosis Meds May Cut Breast Cancer Risk
Analysis from the Women's Health Initiative has found that women who took the bone saving drugs called bisphosphonates had fewer invasive breast... Read more »
Menopause drug tied to breast cancer recurrence
A large study of tibolone, a drug used to treat menopausal symptoms and to prevent osteoporosis, was halted early after researchers found that the... Read more »
Tamoxifen Prevents More Breast Cancer Cases Than Evista
Researchers say the drug tamoxifen prevented more cases of breast cancer after 7 years than the osteoporosis drug Evista, though Evista had fewer... Read more »
Newer drugs boost breast cancer survival--and osteoporosis ris...
Postmenopausal breast cancer patients who switch from tamoxifen therapy to aromatase inhibitors boost their chances for survival from the disease.... Read more »
FDA accepts application for new Osteoporosis med
The U.S. Food and Drug Administration (FDA) has accepted an application for the new osteoporosis medication denosumab. Drugmaker Amgen has applied to... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
